# Treatment Study in Patients Treated With Both Insulin & Hydrocortisone

> **NCT05716607** · NA · NOT_YET_RECRUITING · sponsor: **Vastra Gotaland Region** · enrollment: 16 (estimated)

## Conditions studied

- Diabetes Mellitus
- Adrenal Insufficiency
- Polyglandular Autoimmune Syndrome

## Interventions

- **DRUG:** OD dual-release Hydrocortisone
- **DRUG:** TID Hydrocortisone

## Key facts

- **NCT ID:** NCT05716607
- **Lead sponsor:** Vastra Gotaland Region
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-09
- **Primary completion:** 2025-12
- **Final completion:** 2027-12
- **Target enrollment:** 16 (ESTIMATED)
- **Last updated:** 2024-04-30

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05716607

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05716607, "Treatment Study in Patients Treated With Both Insulin & Hydrocortisone". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05716607. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*